(2025) Emerging frontiers in GLP-1 therapeutics: A comprehensive evidence base
Researchers at Virginia Polytechnic Institute and State University took 20 people living with obesity (half on GLP-1s like semaglutide and tirzepatide, half not), and had them drink alcohol while tracking things like blood alcohol levels, blood sugar, and blood pressure over the course of a few hours
Often individualized due to sedation, and compounded options may help avoid dyes/fillers in sensitive patients
IGF-1 Below Normal Range: Suggests more significant growth hormone deficiency
Similar content being viewed by others Introduction Reduced glutathione (GSH) provides the cellular first line of defense against oxidative stress-induced injury, which can be maintained by NADPH generated mainly via the pentose phosphate pathway and its rate-limiting enzyme, glucose-6-phosphate dehydrogenase (G6PD
Interestingly, a sorghum cultivar of intermediate susceptibility (cv